중동 및 아프리카 오피오이드 시장 전망 2030 - 지역 분석 - 제품별(즉시 방출 단기 작용 오피오이드 및 지속 방출 장기 작용 오피오이드), 응용 분야(통증 관리, 마취, 설사 억제, 기침 억제, 중독 해소 및 기타), 투여 경로(경구, 주사 및 경피 패치), 유통 채널(병원 약국 및 소매 약국)
급증하는 만성 통증 발생률이 중동 및 아프리카 오피오이드 시장을 강화합니다
심혈관 질환, 암, 근골격계 질환, 신경혈관 질환과 같은 만성 질환은 면역력을 저하시켜 사람의 건강에 중대한 영향을 미칩니다. 게다가 이러한 질환을 앓고 있는 많은 환자가 만성 통증을 경험합니다. 위에서 언급한 질환은 성인과 노인 인구에서 가장 흔합니다. 그럼에도 불구하고 이러한 질환의 사례는 어린이에게서도 눈에 띄게 증가하고 있습니다. 만성 통증은 스포츠 선수, 운동 선수 및 과거 부상을 겪은 개인에게도 흔합니다. NCBI(National Center for Biotechnology Information)에 발표된 연구에 따르면 전 세계 성인의 20%가 통증을 겪고 있으며, 10%는 매년 만성 통증으로 새로 진단받습니다. 통증은 성별, 인종/민족, 소득, 연령 또는 지리적 위치에 관계없이 모든 인구에 영향을 미치지만 전 세계적으로 균등하게 분포되지는 않습니다. 하이드로코돈, 옥시코돈 및 모르핀을 포함한 처방 오피오이드는 부상, 수술 및 암과 관절염과 같은 건강 상태로 인한 통증을 치료하는 데 사용되는 강력한 통증 감소 약물입니다.
의회 조사 서비스에 따르면 미국인은 보다 포괄적인 통증 치료를 희생하여 더 많은 오피오이드를 받을 수 있습니다. 오피오이드 처방 관행이 증가한 것은 대체 통증 치료법보다 오피오이드에 인센티브를 제공하는 보험 환불 프로그램, 보다 효율적인 치료를 장려하는 비용 구조 및 환자 만족과 효과적인 통증 관리를 결합하는 평가 때문일 수 있습니다. 따라서 통증 관리에 있어서 오피오이드의 이점 때문에 만성 질환이 있는 환자들 사이에서 수요가 증가하고 있습니다.
중동 및 아프리카 오피오이드 시장 개요
중동 및 아프리카의 오피오이드 시장은 남아프리카, UAE, 사우디 아라비아, 그리고 중동 및 아프리카의 나머지 지역으로 세분화됩니다. 중동 및 아프리카에서 오피오이드는 통증 완화, 완화 치료, 오피오이드 중독 제거에 사용됩니다. 오피오이드 사용 장애에 대한 표준 치료에는 메타돈, 부프레노르핀 또는 날트렉손과 같은 약물을 사용한 치료가 포함됩니다. 이러한 오피오이드 사용 장애(MOUD) 약물은 오피오이드 과다복용으로 인한 사망을 줄입니다. 2020년에 MOUD는 레바논, 모로코, 이란, 팔레스타인 영토에서만 오피오이드 사용 장애에 대한 치료 방법으로 제공되었습니다. 이 지역의 몇몇 국가에서 경제 및 의료 개발이 증가했음에도 불구하고 중동 및 아프리카에서 오피오이드 소비는 제한적으로 증가했습니다.
중동 및 아프리카 오피오이드 시장 수익 및 2030년 예측(백만 달러)
중동 및 아프리카 오피오이드 시장 세분화
중동 및 아프리카 오피오이드 시장은 제품, 응용 분야, 투여 경로, 유통 채널 및 국가로 분류됩니다.
제품을 기준으로 중동 및 아프리카 오피오이드 시장은 즉시 방출 단기 작용 오피오이드와 지속 방출 장기 작용 오피오이드로 세분화됩니다. 즉시 방출 단기 작용 오피오이드 세그먼트는 2022년에 더 큰 시장 점유율을 차지했습니다. 즉시 방출 단기 작용 오피오이드는 옥시코돈, 하이드로코돈, 트라마돌, 코딘, 프로폭시펜 및 기타로 더 세분화됩니다. 지속 방출 장기 작용 오피오이드는 옥시코돈, 펜타닐, 모르핀, 메타돈 및 기타로 더 세분화됩니다.
적용 측면에서 중동 및 아프리카 오피오이드 시장은 통증 관리, 마취, 설사 억제, 기침 억제, 중독 해소 및 기타로 분류됩니다. 통증 관리 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다.
투여 경로별로 중동 및 아프리카 오피오이드 시장은 경구, 주사 및 경피 패치로 세분화됩니다. 경구 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다.
유통 채널별로 중동 및 아프리카 오피오이드 시장은 병원 약국과 소매 약국으로 나뉩니다. 병원 약국 부문은 2022년에 더 큰 시장 점유율을 차지했습니다.
국가별로 중동 및 아프리카 오피오이드 시장은 사우디 아라비아, 남아프리카, UAE 및 기타 중동 및 아프리카로 세분화됩니다. 남아프리카공화국은 2022년에 중동 및 아프리카 오피오이드 시장 점유율에서 우위를 차지했습니다.
Neuraxpharm Pharmaceuticals SL, Endo International plc, Hikma Pharmaceuticals Plc, Mallinckrodt Plc, Rusan Pharma Ltd, Teva Pharmaceutical Industries Ltd는 중동 및 아프리카 오피오이드 시장에서 활동하는 주요 회사 중 일부입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Middle East & Africa Analysis
5.1 Middle East & Africa Opioids Market Overview
5.2 Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030
5.3 Middle East & Africa Opioids Market Forecast Analysis
6. Middle East & Africa Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Middle East & Africa Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Opioids Market - Country Analysis
10.1 Middle East & Africa
10.1.1 Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.2.2 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.2.4 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.2.5 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.2.6 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.3 South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 South Africa: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.3.2 South Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 South Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.3.4 South Africa: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.3.5 South Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.3.6 South Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.4 United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.4.2 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.4.4 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.4.5 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.4.6 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hikma Pharmaceuticals Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Opioids Market Segmentation
Table 2. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 13. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 15. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 19. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 21. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 25. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 31. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 33. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Recent Organic Growth Strategies in Opioids Market
Table 35. Recent Inorganic Growth Strategies in the Opioids Market
Table 36. Glossary of Terms, Opioids Market
List of Figures
Figure 1. Middle East & Africa Opioids Market Segmentation, by Country
Figure 2. Middle East & Africa Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Middle East & Africa Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Middle East & Africa Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Middle East & Africa Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa Opioids Market, by Key Countries, Revenue (2022) (US$ Million)
Figure 23. Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Opioids Market
- Neuraxpharm Pharmaceuticals SL
- Endo International plc
- Hikma Pharmaceuticals Plc
- Mallinckrodt Plc
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa opioids market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa opioids market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.